Chymoral Forte for Ankle Injury with Swelling
Chymoral Forte (trypsin-chymotrypsin) is not recommended as a primary treatment for ankle injury with swelling, as current evidence-based guidelines prioritize functional support (bracing/taping) combined with supervised exercise programs over passive modalities like oral enzymes.
Evidence-Based Treatment Approach
The 2018 British Journal of Sports Medicine guideline 1 establishes the gold standard for ankle sprain management and explicitly states that supervised exercise-based programmes are preferred over passive modalities as they stimulate recovery of functional joint stability. The guideline makes no mention of proteolytic enzymes like Chymoral Forte in their comprehensive treatment algorithm.
Primary Treatment Algorithm
First-line management should consist of:
- Functional support: Tape or semirigid brace (most cost-effective option) 1
- Early mobilization: Brief immobilization (only if needed for severe pain/swelling), followed by early weight-bearing 1
- Supervised exercise program: Active rehabilitation to restore functional joint stability 1
Role of NSAIDs vs. Enzymes
The guideline 1 specifically cautions that NSAIDs may be used for pain and swelling reduction but can suppress natural healing processes. This is critical context when considering any anti-inflammatory agent, including proteolytic enzymes.
Evidence on Chymoral Forte
While some research suggests trypsin-chymotrypsin may reduce inflammation and edema 2, 3, the evidence has significant limitations:
- Outdated research: The mechanism of action remains "vague" and therapeutic value "uncertain" even in older literature 4
- Lack of guideline support: No major sports medicine or orthopedic guideline recommends proteolytic enzymes for acute ankle injuries 1, 5
- Questionable superiority: Recent trials 3 show trypsin-chymotrypsin may reduce wound symptoms after orthopedic surgery, but these were controlled surgical wounds, not acute traumatic ankle sprains
Critical Caveat
The FDA drug label provided 6 appears to be for "Calms Forté" (a homeopathic sleep aid), not Chymoral Forte. This is a completely different product and should not be confused with the proteolytic enzyme preparation.
Practical Dosing (If Used Despite Lack of Guideline Support)
If a clinician chooses to use trypsin-chymotrypsin despite the lack of guideline recommendation, typical dosing from research studies is:
- 2 tablets orally three times daily for 7-10 days 3, 7
- Take on empty stomach for optimal absorption (general enzyme principle)
Precautions
- Avoid in bleeding disorders due to fibrinolytic activity 8
- Monitor for allergic reactions (though safety profile appears favorable in recent trials 9, 10)
- Do not use as monotherapy—must be combined with functional support and exercise 1
Bottom Line
Prioritize evidence-based functional treatment (brace + exercise) over oral enzymes. The 2018 guideline 1 emphasizes that passive modalities should not replace active rehabilitation. If Chymoral Forte is considered, it should only be as an adjunct to—never a replacement for—functional support and supervised exercise, which have the strongest evidence for preventing chronic ankle instability and optimizing long-term outcomes.